114 related articles for article (PubMed ID: 17545482)
1. Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction.
Rodenbaugh DW; Wang W; Davis J; Edwards T; Potter JD; Metzger JM
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1705-13. PubMed ID: 17545482
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action.
Day SM; Coutu P; Wang W; Herron T; Turner I; Shillingford M; Lacross NC; Converso KL; Piao L; Li J; Lopatin AN; Metzger JM
Physiol Genomics; 2008 May; 33(3):312-22. PubMed ID: 18334547
[TBL] [Abstract][Full Text] [Related]
3. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
Coutu P; Bennett CN; Favre EG; Day SM; Metzger JM
Circ Res; 2004 May; 94(9):1235-41. PubMed ID: 15059934
[TBL] [Abstract][Full Text] [Related]
4. Effects of Modified Parvalbumin EF-Hand Motifs on Cardiac Myocyte Contractile Function.
Asp ML; Sjaastad FV; Siddiqui JK; Davis JP; Metzger JM
Biophys J; 2016 May; 110(9):2094-105. PubMed ID: 27166817
[TBL] [Abstract][Full Text] [Related]
5. Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies.
Coutu P; Metzger JM
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H601-12. PubMed ID: 15331372
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes.
Huq F; Lebeche D; Iyer V; Liao R; Hajjar RJ
Circulation; 2004 Jun; 109(22):2780-5. PubMed ID: 15173024
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction.
Hirsch JC; Borton AR; Albayya FP; Russell MW; Ohye RG; Metzger JM
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2314-21. PubMed ID: 15148059
[TBL] [Abstract][Full Text] [Related]
8. Genetic manipulation of calcium-handling proteins in cardiac myocytes. II. Mathematical modeling studies.
Coutu P; Metzger JM
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H613-31. PubMed ID: 15331371
[TBL] [Abstract][Full Text] [Related]
9. Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction.
Wang W; Martindale J; Metzger JM
Gen Physiol Biophys; 2009; 28 Spec No Focus():F3-6. PubMed ID: 20093724
[TBL] [Abstract][Full Text] [Related]
10. Parvalbumin isoforms for enhancing cardiac diastolic function.
Wang W; Metzger JM
Cell Biochem Biophys; 2008; 51(1):1-8. PubMed ID: 18458829
[TBL] [Abstract][Full Text] [Related]
11. Parvalbumin gene delivery improves diastolic function in the aged myocardium in vivo.
Michele DE; Szatkowski ML; Albayya FP; Metzger JM
Mol Ther; 2004 Aug; 10(2):399-403. PubMed ID: 15294186
[TBL] [Abstract][Full Text] [Related]
12. Gene Transfer of Calcium-Binding Proteins into Adult Cardiac Myocytes.
Thompson BR; Cohen H; Angulski ABB; Metzger JM
Methods Mol Biol; 2019; 1929():187-205. PubMed ID: 30710274
[TBL] [Abstract][Full Text] [Related]
13. Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance.
Wang W; Barnabei MS; Asp ML; Heinis FI; Arden E; Davis J; Braunlin E; Li Q; Davis JP; Potter JD; Metzger JM
Nat Med; 2013 Mar; 19(3):305-12. PubMed ID: 23396207
[TBL] [Abstract][Full Text] [Related]
14. Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes.
Wahr PA; Michele DE; Metzger JM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11982-5. PubMed ID: 10518562
[TBL] [Abstract][Full Text] [Related]
15. Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes.
Nagata K; Liao R; Eberli FR; Satoh N; Chevalier B; Apstein CS; Suter TM
Cardiovasc Res; 1998 Feb; 37(2):467-77. PubMed ID: 9614501
[TBL] [Abstract][Full Text] [Related]
16. Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes.
Yasuda S; Coutu P; Sadayappan S; Robbins J; Metzger JM
Circ Res; 2007 Aug; 101(4):377-86. PubMed ID: 17615373
[TBL] [Abstract][Full Text] [Related]
17. Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling.
Coutu P; Metzger JM
Biophys J; 2002 May; 82(5):2565-79. PubMed ID: 11964244
[TBL] [Abstract][Full Text] [Related]
18. Method-related effects of adenovirus-mediated LacZ and SERCA1 gene transfer on contractile behavior of cultured failing human cardiomyocytes.
Weisser-Thomas J; Dieterich E; Janssen PM; Schmidt-Schweda S; Maier LS; Sumbilla C; Pieske B
J Pharmacol Toxicol Methods; 2005; 51(2):91-103. PubMed ID: 15767202
[TBL] [Abstract][Full Text] [Related]
19. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
[TBL] [Abstract][Full Text] [Related]
20. Myocardial energetics is not compromised during compensated hypertrophy in the Dahl salt-sensitive rat model of hypertension.
Tran K; Han JC; Taberner AJ; Barrett CJ; Crampin EJ; Loiselle DS
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H563-71. PubMed ID: 27402668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
